AAAAAA
Results:
1-7
|
Results: 7
Authors:
SAILER M
BURCHERT W
EHRENHEIM C
SMID HGOM
HAAS J
WILDHAGEN K
WURSTER U
DEICHER H
Citation: M. Sailer et al., POSITRON EMISSION TOMOGRAPHY AND MAGNETIC-RESONANCE-IMAGING FOR CEREBRAL INVOLVEMENT IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Journal of neurology, 244(3), 1997, pp. 186-193
Authors:
RUNGE M
RYKENA S
WILDHAGEN K
DEICHER H
KIRCHHOFF H
Citation: M. Runge et al., DETECTION OF UREAPLASMA-UREALYTICUM IN URINE OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND HEALTHY-INDIVIDUALS BY CULTURE AND POLYMERASE CHAIN-REACTION, Journal of Medical Microbiology, 46(5), 1997, pp. 413-418
Authors:
WILDHAGEN K
LAKOMEK HJ
Citation: K. Wildhagen et Hj. Lakomek, HEMOLYSIS DURING SULFASALAZINE THERAPY IN A PATIENT WITH UNDIFFERENTIATED SPONDYLARTHROPATHY, Aktuelle Rheumatologie, 21(3), 1996, pp. 142-143
Authors:
WILDHAGEN K
WOLL R
Citation: K. Wildhagen et R. Woll, DAMAGE FROM EXPOSURE TO ULTRAVIOLET AND I NFRARED LIGHT, Deutsche Medizinische Wochenschrift, 119(9), 1994, pp. 323-323
Authors:
WILDHAGEN K
HARTUNG K
HAMMER M
MAU W
SCHMIDT RE
DEICHER H
ZEIDLER H
Citation: K. Wildhagen et al., DRUG-RELATED LUPUS IN A PATIENT WITH RHEUMATOID-ARTHRITIS UNDER SULFASALAZINE TREATMENT, Clinical rheumatology, 12(2), 1993, pp. 265-267
Authors:
WILDHAGEN K
WOLL R
DEICHER H
Citation: K. Wildhagen et al., CASE-REPORT - SYSTEMIC LUPUS-ERYTHEMATOSU S PATIENTS AT RISK DUE TO UNPROTECTED EXPOSURE TO UNSUBDUED HALOGEN LAMPS, Aktuelle Rheumatologie, 18(5), 1993, pp. 167-169
Authors:
MIELKE H
WILDHAGEN K
MAU W
ZEIDLER H
Citation: H. Mielke et al., FOLLOW-UP OF PATIENTS WITH DOUBLE-STRANDED DNA ANTIBODIES INDUCED BY SULFASALAZINE DURING THE TREATMENT OF INFLAMMATORY RHEUMATIC DISEASES, Scandinavian journal of rheumatology, 22(6), 1993, pp. 299-301
Risultati:
1-7
|